| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5941305510c5714dfa0a0d94047e1e04 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14252 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-42 |
| filingDate |
2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbd6e41cdac850e71ce7644e5dbd878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce272e67d337d3283cb8bac3254a2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbced2b089d4d37311c54dc90a517d1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_112053048edcb65e6172b3e59ca8cf54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06089b17f35c8a5a60d06dfa9a9daea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f56af65816ec124ac0b7294a052d00f4 |
| publicationDate |
2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019134369-A1 |
| titleOfInvention |
Transdermal drug delivery device |
| abstract |
A transdermal drug delivery device is disclosed that may comprise a housing including an upper housing portion and a lower housing portion. The lower housing portion may define a bottom surface including skin attachment means for releasably attaching the lower housing portion to skin of a user. The upper housing portion may at least partially surround a central region of the device. The device may also include a microneedle assembly and a reservoir disposed within the central region. The reservoir may be in fluid communication with the microneedle assembly. Additionally, the device may include a pushing element disposed above the microneedle assembly within the central region. The pushing element may be configured to provide a continuous bilateral force having a downward component transmitted through the microneedle assembly and an upward component transmitted through the skin attachment means. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452852-B2 |
| priorityDate |
2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |